| Literature DB >> 23950630 |
Victor Dinda1, Revathi Gunturu, Sam Kariuki, Abdi Hakeem, Asad Raja, Andrew Kimang'a.
Abstract
BACKGROUND: In low income countries, surgical site infections (SSIs) are costly and impose a heavy and potentially preventable burden on both patients and healthcare providers. This study aimed to determine the occurrence of SSI, pathogens associated with SSI, the antibiogram of the causative pathogens and specific risk factors associated with SSI at the hospital.Entities:
Keywords: Antibiotics; Infection; Surgical sites; Surveillance
Mesh:
Substances:
Year: 2013 PMID: 23950630 PMCID: PMC3742891
Source DB: PubMed Journal: Ethiop J Health Sci ISSN: 1029-1857
Incidence rates of surgical site infection
| Frequency | Incidence % | |||||
| All infections after surgery | 39(268) | 14.60 | ||||
| True SSI | 12(171) | 7.00 | ||||
| Clean wound surgery | 5(91) | 5.50 | 0.506 | |||
| Clean contaminated wound surgery | 7(80) | 8.80 | 0.613 | |||
| Contaminated wound surgery | 6(30) | 20.00 | 0.09 | |||
| Dirty wound surgery | 20(67) | 29.90 | 0.003 | |||
| Male | 15(79) | 18.90 | 0.082 | |||
| Female | 24(189) | 12.70 | 0.075 | |||
| Abdominal | 10 (39) | 25.64 | 0.093 | |||
| Neck | 2 (38) | 5.26 | 1.348 | |||
| Thorax | 7 (39) | 17.95 | 0.276 | |||
| Head | 0(40) | 0.00 | - | |||
| Perineum | 10(39) | 25.64 | 0.093 | |||
| Upper Limbs | 3 (39) | 7.69 | 0.308 | |||
| Lower Limbs | 7 (39) | 17.95 | 0.543 | |||
| ≤18.4 | 5(74) | 6.76 | 0.073 | |||
| 18.5–24.9 | 14(158) | 8.86 | 0.098 | |||
| ≥25 | 20(36) | 55.56 | 0.156 | |||
| Less than a day | 4(23) | 17.39 | 0.135 | |||
| 2 days | 5(15) | 33.33 | 0.002 | |||
| 3 days | 3(12) | 0.25 | 0.05 | |||
| 4 days | 2(2) | 100.00 | 0.04 | |||
| 5 days | 3(3) | 100.00 | 0.048 | |||
| 7 days | 2(4) | 50.00 | 0.037 | |||
| > 7 days | 6(30) | 20.00 | 0.024 | |||
| ASA Grade 1 | 27(197) | 13.71 | 0.079 | |||
| ASA Grade 2 | 9(46) | 19.56 | 0.084 | |||
| ASA Grade 3 | 3(25) | 12.00 | 0.068 | |||
| No | 25(190) | 13.16 | 0.459 | |||
| Yes | 14 (78) | 17.95 | 0.067 | |||
*Key
SSI occurence (number of surgery in the category)
True SSI Rate = (SSI occurrence in Clean and clean contaminated/Total Clean and Clean contaminated Surgical procedure X 100)
Bacteria isolated from the study subjects
| Preoperative culture | Intraoperative | Postoperative | ||||
| Organisms | Nasal | Axilla | Groin | Perianal | ||
| Coagulase negative | ||||||
| 94 | 62 | 20 | 0 | 1 | 6(15.4%) | |
| 0 | 0 | 8 | 58 | 2 | 5(12.8%) | |
| 34 | 27 | 0 | 0 | 1 | 12(30.8%) | |
| 1 | 0 | 2 | 10 | 0 | 5(12.8%) | |
| 0 | 0 | 5 | 8 | 0 | 5(12.8%) | |
| 0 | 3 | 2 | 0 | 0 | 0 (0) | |
| 0 | 0 | 8 | 5 | 0 | 0 (0) | |
| 0 | 0 | 1 | 0 | 0 | 4 (10.3%) | |
| 0 | 0 | 0 | 4 | 0 | 0 (0) | |
| 0 | 0 | 0 | 1 | 0 | 0 (0) | |
| 0 | 0 | 0 | 0 | 0 | 1(2.6%) | |
| 0 | 0 | 0 | 0 | 0 | 1 (2.6%) | |
Antibiotic susceptibility pattern for S. aureus and CN staphylococcus isolated from SSI
| Frequency of Resistance | ||
| Antibiotic | CN | |
| Ampicillin | ||
| Doxycycline | ||
| Azithromycin | ||
| Augmentin | ||
| Cefuroxime | ||
| Ciprofloxacin | ||
| Chloramphenicol | ||
| Oxacillin | ||
| Netilmicin | ||
| Vancomycin | ||
Antibiotic susceptibility pattern for gram negative bacteria isolated from SSI
| Frequency of Resistance | ||||
| Antibiotics | ||||
| Cotrimoxazole | - | |||
| Doxycycline | - | |||
| Augmentin | - | |||
| Cefotaxime | - | |||
| Chloramphenicol | - | |||
| Cefuroxime | - | |||
| Ciprofloxacin | ||||
| Gentamicin | ||||
| Tazo-piperacillin | - | - | - | |
| Cefepime | - | - | - | |
| Ceftazidime | - | - | - | |
| Imipenem | - | - | - | |
| Piperacillin | - | - | - | |
| Ceftriaxone | - | - | - |
Key
E. cloacae and Serratia marcescens susceptibility pattern not included because only one (1) of each was isolated in SSI
- Not tested
Association of corneal opacity and potential risk factors, eye level analysis (n=596)
| Risk factor | Total no | Eyes with | Percentage of eyes | Univariate analysis | Multivariate analysis | |||||||
| Odds | 95% CI | P value | P value | Odds | 95% CI | P value | P value | |||||
| Male | 188 | 29 | 15.4 | 1.0 | 1.0 | |||||||
| Female | 408 | 44 | 10.8 | 0.6 | 0.4–1.2 | 0.14 | 0.7 | 0.3–1.4 | 0.314 | |||
| <45 | 197 | 12 | 6.1 | 1.0 | 1.3–6.3 | 0.01 | <0.001 | 1.0 | 1.3–6.6 | 0.008 | 0.001 | |
| Illiterate | 549 | 71 | 12.9 | 1.0 | 0.04–1.1 | 0.06 | ||||||
| 0–12 months | 495 | 54 | 10.9 | 1.0 | 1.2–4.9 | 0.01 | 1.0 | 1.3–5.5 | 0.007 | |||
| Yes | 442 | 51 | 11.5 | 1.0 | ||||||||
| No | 154 | 22 | 14.3 | 1.2 | 0.7–2.3 | 0.54 | ||||||
| Once a week or more | 223 | 21 | 9.4 | 1.0 | 0.24 | |||||||
| < Once a week | 218 | 30 | 13.8 | 1.6 | 0.8–3.1 | 0.20 | ||||||
| Not at all | 155 | 22 | 14.2 | 1.5 | 0.7–3.1 | 0.26 | ||||||
| No | 511 | 54 | 10.6 | 1.0 | 1.3–4.7 | 0.01 | 1.0 | 1.4–5.9 | <0.01 | |||
| No | 556 | 63 | 11.3 | 1.0 | 1.1–6.4 | 0.03 | 1.0 | 1.0–6.3 | 0.042 | |||